Two large drug makers are squaring off against the Netherlands as drug pricing increasingly becomes a flashpoint for governments looking to pay less for medicines.
In one instance, Vertex Pharmaceuticals (VRTX) has reportedly filed a lawsuit against the Ministry for Medical Care over the methods used to calculate the official maximum price for Orkambi, a cystic fibrosis treatment that is also at the center of a closely watched row over reimbursement in the U.K.
About the Author Reprints
